News
Stay up to date on topics that are important to Nurse Practitioners.
-
Vaginal Gel Approved for Bacterial Vaginosis
The FDA approved clindamycin phosphate vaginal gel, 2% (Xaciato), for the treatment of bacterial vaginosis in females 12…
-
FDA Approves Three-Antigen Hepatitis B Vaccine
The FDA approved a new hepatitis B vaccine [recombinant]) (PreHevbrio) for the prevention of infection caused by all…
-
First Liquid Topiramate Formulation Approved for Seizure Indication
The FDA has approved the first ready-to-use liquid formulation of topiramate (Eprontia oral solution) for partial-onset, primary generalized…
-
Younger Patients Now Indicated for Asthma Drug
The FDA expanded the approved indications for dupilumab (Dupixent) injection to include add-on maintenance treatment of patients 6…
-
FDA Expands Eligibility for COVID-19 Boosters to All Adult
The FDA amended the emergency use authorization (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines authorizing use…
-
CDC Recommends Pfizer COVID-19 Vaccine for Children 5 to 11 Years
CDC Director Rochelle Walensky, MD, MPH, officially endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation that…
-
Pneumococcal Vax Guideline Update
ACIP voted in favor of updates to the pneumococcal vaccination recommendations that (1) adults 65 years of age…
-
Pfizer Seeks Emergency Use Authorization for COVID-19 Oral Antiviral
Pfizer is seeking emergency use authorization (EUA) for its investigational COVID-19 oral antiviral PF-07321332/ritonavir (Paxlovid) for the treatment…
-
Hepatitis B Virus/Ebola/Smallpox, Monkeypox
In another ACIP meeting, the group unanimously voted to recommend universal hepatitis B virus (HBV) immunization in all…
-
Shingrix Recommended for Immunocompromised Adults Ages 19+
The US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted unanimously to…
-
CDC Updates Recommendations for 2021-22 Influenza Season
The CDC’s Advisory Committee on Immunization Practices (ACIP) issued its updated recommendations for the use of seasonal influenza…
-
October 2021 COVID-19 News
FDA Authorizes Pfizer/BioNTech COVID-19 Vaccine for Children Ages 5 to 11 The FDA approved the emergency use of…
Trending
-
FDA Approved Semaglutide Injection to Reduce Risk of Serious Heart Problems in Overweight Adults
-
The Role of Pharmacogenomics in Precision Mental Healthcare
-
OTC COVID-19 Diagnostic Tests May Have an Extended Shelf Life
-
AANP Offers Resources to Help NPs Detect and Treat Ulcerative Colitis
-
Multistate Outbreak of Salmonella Linked to Cucumbers
-
5 Key Benefits of Getting a Second Certification as a Nurse Practitioner
-
8 Key Tips for Effective Communication During Pediatric ENT Exams
-
Normalizing Anxiety: How NPs Can Guide Patients to Make Healthier Choices
-
CDC Endorses Lowering Pneumococcal Vaccination Age from 65 to 50
-
FDA Proposes Ban on Over-the-Counter Oral Nasal Congestion Medication
-
Using Technology to Combat Drug-Drug Interactions
-
Building a Strong Professional Nursing Network as a New Nurse Practitioner
Join our email list
Get new course alerts, newsletters and more delivered directly to your inbox
By providing my personal information, including phone number, I consent to (1) receive email messages with information and offers, autodialed calls, texts, and prerecorded messages from FHEA, including current and possible future services, customer service and billing; and (2) FHEA’s Privacy Policy and Terms and Conditions. I understand that my consent is not required to purchase, and that cancellation of purchase does not automatically revoke this consent.